Cantitate/Preț
Produs
Total produse
Vezi coșul
Translational Neuropsychopharmacology de Trevor W. Robbins

Translational Neuropsychopharmacology: Current Topics in Behavioral Neurosciences, cartea 28

Editat de Trevor W. Robbins, Barbara J. Sahakian
en Limba Engleză Hardback – 6 iun 2016
This book covers wide areas of animal and human psychopharmacology with clinical utility in the treatment of psychiatric and neurological (e.g Alzheimer's disease) disorders. The main theme is to develop a new paradigm for drug discovery that questions the claim that animal models or assays fail adequately to predict Phase 3 clinical trials. A new paradigm is advocated that stresses the importance of intermediate staging points between these extremes that depend on suitable translation of findings from animal studies to Phase 1 or Phase 2 studies utilising experimental medicine.  
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 95462 lei  6-8 săpt.
  Springer International Publishing – 30 mai 2018 95462 lei  6-8 săpt.
Hardback (1) 96865 lei  6-8 săpt.
  Springer International Publishing – 6 iun 2016 96865 lei  6-8 săpt.

Din seria Current Topics in Behavioral Neurosciences

Preț: 96865 lei

Preț vechi: 118128 lei
-18% Nou

Puncte Express: 1453
Preț estimativ în valută:
18538€ • 19282$ • 15304£

Carte tipărită la comandă

Livrare economică 14-28 aprilie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319339115
ISBN-10: 3319339117
Pagini: 510
Ilustrații: XII, 498 p. 124 illus., 92 illus. in color.
Dimensiuni: 155 x 235 x 33 mm
Greutate: 1.11 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Springer
Seria Current Topics in Behavioral Neurosciences

Locul publicării:Cham, Switzerland

Cuprins

Translational mouse models of autism; Advancing towards pharmacological therapeutics.- Translatable and back-translatable measurement of impulsivity and compulsivity; convergent and divergent processes.- Translational models of gambling-related decision-making.- Translational research on nicotine dependence.- The need for treatment-responsive translatable biomarkers in alcoholism research.- On the road to translation for PTSD treatment: theoretical and practical considerations of the use of human models of conditioned fear for drug development.- Translational approaches targeting reconsolidation.- Translational assessment of reward and motivational deficits in psychiatric disorders.-                Affective biases in humans and animals. Robinson.- Locomotor profiling from the rodents to the clinic and back again.- Animal models of sensori-motor gating in schizophrenia: Are they still relevant?.- Attention and the cholinergic system: relevance to schizophrenia.- Attentional-set-shifting across species.- Relating Translational Neuroimaging and Amperometric Endpoints: Utility for Neuropsychiatric Drug Discovery.- Cognitive translation using the rodent touchscreen test approach.- The Paired Associates Learning (PAL) Test:  30 years of CANTAB Translational Neuroscience From Laboratory to Bedside in Dementia Research.- Translational approaches to experimental medicine.

Recenzii

“This book examines the ‘translational gap’ between animal models of neuropsychiatric disease and human studies. … The intended audience is scientists working on problems related to neuropsychopharmacology. … This is an important addition to the literature on translational neurosciences. It is an important contribution to understanding both the current state of this field and its possible future directions.” (Eric Gausche, Doody's Book Reviews, November, 2016)

Textul de pe ultima copertă

This book covers wide areas of animal and human psychopharmacology with clinical utility in the treatment of psychiatric and neurological (e.g Alzheimer's disease) disorders. The main theme is to develop a new paradigm for drug discovery that questions the claim that animal models or assays fail adequately to predict Phase 3 clinical trials. A new paradigm is advocated that stresses the importance of intermediate staging points between these extremes that depend on suitable translation of findings from animal studies to Phase 1 or Phase 2 studies utilising experimental medicine.  

Caracteristici

Translational (neuro)psychopharmacology is the application of basic neuroscience and psychopharmacology to the treatment of psychiatric and neurological disorders - which remain our largest health and socio-economic burden There are currently no books on the subject There are relatively few investigators who have managed to bridge the 'translational gap'; many of them are represented in the current list of possible contributors Includes supplementary material: sn.pub/extras